Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β
- PMID:21968503
- DOI: 10.1097/MCA.0b013e32834a3817
Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β
Abstract
Objective: An increased expression of plasminogen activator inhibitor type-1 (PAI-1) has been implicated in accelerating atherogenesis and coronary artery disease in patients with type 2 diabetes. Transforming growth factor (TGF)-β increases its expression. An increased PAI-1 appears to predispose also to augmented fibrosis potentially contributing to negative left ventricular remodeling and heart failure after myocardial infarction. Diabetes is well known to induce oxidative stress. To elucidate molecular mechanisms underlying an increased PAI-1 production, the effects of TGF-β and oxidative stress implicated as agonists of PAI-1 synthesis were characterized with the use of human liver-derived HepG2 cells.
Methods: PAI-1 mRNA was assayed by real-time PCR, and PAI-1 protein was assayed by western blotting. PAI-1 promoter (-825 -+42 bp) activity was assessed with the luciferase assay. The role of the 3'-untranslated region was delineated with the use of luciferase constructs containing the 3'-untranslated region. Oxidative stress was measured after loading carboxy-2,7-dichlorodihydrofluorescein into cells.
Results: TGF-β increased oxidative stress, which was accompanied by increases in NADPH oxidase 3 mRNA and membrane translocation of Rac proteins. TGF-β-inducible increases in the PAI-1 promoter activity involved Smad-binding elements and a nuclear factor-κB-binding site. TGF-β did not increase the activity of the PAI-1 mRNA 3'-untranslated region. TGF-β-inducible PAI-1 expression was attenuated by simvastatin and curcumin, a natural polyphenol.
Conclusion: TGF-β can increase the expression of PAI-1 through multiple mechanisms involving Smad and nuclear factor-κB pathways and oxidative stress. As both oxidative stress and PAI-1 production were reduced by simvastatin and curcumin, modulation of oxidative stress and PAI-1 production are attractive targets for pharmacotherapy of cardiovascular disorders associated with an increased PAI-1 including type 2 diabetes and its associated consequences including accelerated coronary artery disease and an increased fibrosis that may exacerbate adverse left ventricular remodeling after myocardial infarction.
Similar articles
- Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.Miyagawa R, Asakura T, Nakamura T, Okada H, Iwaki S, Sobel BE, Fujii S.Miyagawa R, et al.Coron Artery Dis. 2010 May;21(3):144-50. doi: 10.1097/MCA.0b013e328335790e.Coron Artery Dis. 2010.PMID:20299979
- Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.Allen RR, Qi L, Higgins PJ.Allen RR, et al.J Cell Physiol. 2005 Apr;203(1):156-65. doi: 10.1002/jcp.20211.J Cell Physiol. 2005.PMID:15372465
- Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.Hageman J, Eggen BJ, Rozema T, Damman K, Kampinga HH, Coppes RP.Hageman J, et al.Clin Cancer Res. 2005 Aug 15;11(16):5956-64. doi: 10.1158/1078-0432.CCR-05-0427.Clin Cancer Res. 2005.PMID:16115939
- Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.Samarakoon R, Higgins PJ.Samarakoon R, et al.Thromb Haemost. 2008 Dec;100(6):976-83.Thromb Haemost. 2008.PMID:19132220Free PMC article.Review.
- The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1.Samarakoon R, Higgins SP, Higgins CE, Higgins PJ.Samarakoon R, et al.Biomolecules. 2019 Aug 3;9(8):341. doi: 10.3390/biom9080341.Biomolecules. 2019.PMID:31382626Free PMC article.Review.
Cited by
- Anti-fibrotic effects of curcumin and some of its analogues in the heart.Gorabi AM, Hajighasemi S, Kiaie N, Rosano GMC, Sathyapalan T, Al-Rasadi K, Sahebkar A.Gorabi AM, et al.Heart Fail Rev. 2020 Sep;25(5):731-743. doi: 10.1007/s10741-019-09854-6.Heart Fail Rev. 2020.PMID:31512150Review.
- Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.Thomsen LH, Fog-Tonnesen M, Nielsen Fink L, Norlin J, García de Vinuesa A, Hansen TK, de Heer E, Ten Dijke P, Rosendahl A.Thomsen LH, et al.Ren Fail. 2017 Nov;39(1):629-642. doi: 10.1080/0886022X.2017.1361837.Ren Fail. 2017.PMID:28805484Free PMC article.
- A Novel Y-Specific Long Non-Coding RNA Associated with Cellular Lipid Accumulation in HepG2 cells and Atherosclerosis-related Genes.Molina E, Chew GS, Myers SA, Clarence EM, Eales JM, Tomaszewski M, Charchar FJ.Molina E, et al.Sci Rep. 2017 Dec 1;7(1):16710. doi: 10.1038/s41598-017-17165-9.Sci Rep. 2017.PMID:29196750Free PMC article.
- Inflammation and oxidative stress caused by nitric oxide synthase uncoupling might lead to left ventricular diastolic and systolic dysfunction in patients with hypertension.Szelényi Z, Fazakas Á, Szénási G, Kiss M, Tegze N, Fekete BC, Nagy E, Bodó I, Nagy B, Molvarec A, Patócs A, Pepó L, Prohászka Z, Vereckei A.Szelényi Z, et al.J Geriatr Cardiol. 2015 Jan;12(1):1-10. doi: 10.11909/j.issn.1671-5411.2015.01.001.J Geriatr Cardiol. 2015.PMID:25678898Free PMC article.
- NADPH Oxidase 3: Beyond the Inner Ear.Herb M.Herb M.Antioxidants (Basel). 2024 Feb 8;13(2):219. doi: 10.3390/antiox13020219.Antioxidants (Basel). 2024.PMID:38397817Free PMC article.Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous